Delta Biopharma Private Limited, a active private limited company, was established on 08 December 2012 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100MH2012PTC238604. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹50.20 Cr and a paid-up capital of ₹50.00 Cr.
It upholds a compliant status. Employing 175 professional, Its leadership includes Rajiv Khanna (Director), Chander Mohan Khanna (Director), Rita Khanna (Director). Past directors included Rajiv Khanna, Jyoti Rani, Rajni Anil Sharma. It holds ₹2.70 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 1017/1018 Corporate Avenue Sonawala Road, Goregaon East, Mumbai, Maharashtra, 400063.
U24100MH2012PTC238604
238604
08 December 2012
₹50.20 Cr
₹50.00 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Delta Biopharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajiv Khanna | Director | 31 Mar 2015 | Current |
| Chander Mohan Khanna | Director | 08 Dec 2012 | Current |
| Rita Khanna | Director | 08 Dec 2012 | Current |
| Rajat Chander Mohan Khanna | Director | 08 Dec 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Company Secretary | 01 Aug 2025 | Past |
| Pramod Abcsdd | Company Secretary | - | Past |
| Pramod Abcsdd | Additional Director | 20 Dec 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Delta Biopharma Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 2.37% decrease. The company also saw a substantial improvement in profitability, with a 22.62% increase in profit. The company's net worth observed a substantial decline by a decrease of 29.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Delta Biopharma had a promoter holding of 28.71% and a public holding of 71.29%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹27,039,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Mar 2022 | Axis Bank Limited | ₹2.70 Cr | Open |
Explore comprehensive loan charge details -
Delta Biopharma has a workforce of 175 employees as of Sep 22, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Delta Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Delta Biopharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Jaya Sharma was appointed as a Company Secretary was appointed as a Company Secretary on 22 Aug 2025 & has been associated with this company since 3 months 8 days . was completed.
Progress on Delta Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Delta Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
A charge with Axis Bank Limited amounted to Rs. 2.70 Cr with Charge ID 100553489 was registered on 26 Mar 2022. was recorded as a recent event.
Progress on Rajiv Khanna was appointed as a Director was appointed as a Director on 31 Mar 2015 & has been associated with this company since 10 years 8 months . was documented.
Progress on Chander Mohan Khanna was appointed as a Director was appointed as a Director on 08 Dec 2012 & has been associated with this company since 12 years 11 months . was documented.
The CIN of Delta Biopharma Private Limited is U24100MH2012PTC238604.
Delta Biopharma Private Limited is headquartered at 1017/1018 Corporate Avenue Sonawala Road, Goregaon East, Mumbai, Maharashtra, 400063.
Delta Biopharma Private Limited was incorporated on 08 December 2012.
The current directors of Delta Biopharma Private Limited are
The primary industry of Delta Biopharma Private Limited is Manufacturing.
Delta Biopharma Private Limited is unlisted.
The authorized capital of Delta Biopharma Private Limited is ₹50.20 Cr, and the paid-up capital is ₹50.00 Cr.
The compliance status of Delta Biopharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX